In Vivo Pharmacodynamics of a New Triazole, Ravuconazole, in a Murine Candidiasis Model
In vivo studies have characterized the pharmacodynamic characteristics of the triazole fluconazole. These investigations demonstrated that the ratio of the area under the concentration-time curve from 0 to 24 h to the MIC (24-h AUC/MIC ratio) is the critical pharmacokinetic/pharmacodynamic (PK/PD) p...
Сохранить в:
| Опубликовано в:: | Antimicrob Agents Chemother |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology (ASM)
2003
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC152484/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12654646/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.4.1193-1199.2003 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|